Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2023-11-15 Sale |
2024-01-04 8:09 pm |
Protagonist Therapeutics Inc | PTGX | MOLINA ARTURO MD Chief Medical Officer |
1,848 | $16.24 | $30,012 | 146,277 (Direct) |
View |
| 2023-12-13 Sale |
2023-12-15 4:30 pm |
Protagonist Therapeutics Inc | PTGX | PATEL DINESH V PH D President and CEO |
75,000 | $20.08 | $1,506,000 | 534,347 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2024-01-02 Option Award |
2024-01-04 8:17 pm |
N/A 2034-01-02 |
Protagonist Therapeutics Inc | PTGX | O'Dowd Sarah A Director |
25,700 | $0 | 25,700 (Direct) |
View |
| 2024-01-02 Option Award |
2024-01-04 8:15 pm |
N/A 2034-01-02 |
Protagonist Therapeutics Inc | PTGX | Gupta Suneel Chief Development Officer |
90,750 | $0 | 259,067 (Direct) |
View |
| 2024-01-02 Option Award |
2024-01-04 8:14 pm |
N/A 2034-01-02 |
Protagonist Therapeutics Inc | PTGX | Williams Lewis T Director |
25,700 | $0 | 25,700 (Direct) |
View |
| 2024-01-02 Option Award |
2024-01-04 8:13 pm |
N/A 2034-01-02 |
Protagonist Therapeutics Inc | PTGX | SELICK HAROLD E Director |
25,700 | $0 | 25,700 (Direct) |
View |
| 2024-01-02 Option Award |
2024-01-04 8:11 pm |
N/A 2034-01-02 |
Protagonist Therapeutics Inc | PTGX | PATEL DINESH V PH D President and CEO |
400,125 | $0 | 934,472 (Direct) |
View |
| 2024-01-02 Option Award |
2024-01-04 8:10 pm |
N/A 2034-01-02 |
Protagonist Therapeutics Inc | PTGX | Giraudo Bryan Director |
25,700 | $0 | 25,700 (Direct) |
View |
| 2024-01-02 Option Award |
2024-01-04 8:09 pm |
N/A 2034-01-02 |
Protagonist Therapeutics Inc | PTGX | MOLINA ARTURO MD Chief Medical Officer |
123,750 | $0 | 146,277 (Direct) |
View |
| 2024-01-02 Option Award |
2024-01-04 8:07 pm |
N/A 2034-01-02 |
Protagonist Therapeutics Inc | PTGX | Ali Asif Chief Financial Officer |
99,000 | $0 | 130,036 (Direct) |
View |
| 2023-10-26 Option Award |
2023-10-30 4:31 pm |
N/A 2033-10-26 |
Protagonist Therapeutics Inc | PTGX | Swisher Daniel N JR Director |
45,000 | $0 | 45,000 (Direct) |
View |
| 2023-10-19 Exercise |
2023-10-23 4:31 pm |
N/A N/A |
Protagonist Therapeutics Inc | PTGX | Gupta Suneel Chief Development Officer |
20,000 | $7.38 | 218,317 (Direct) |
View |
| 2023-10-19 Exercise |
2023-10-23 4:31 pm |
N/A 2029-01-14 |
Protagonist Therapeutics Inc | PTGX | Gupta Suneel Chief Development Officer |
20,000 | $0 | 218,317 (Direct) |
View |
| 2023-10-18 Exercise |
2023-10-19 4:55 pm |
N/A 2026-04-29 |
Protagonist Therapeutics Inc | PTGX | PATEL DINESH V PH D President and CEO |
6,000 | $0 | 663,347 (Direct) |
View |
| 2023-10-18 Exercise |
2023-10-19 4:55 pm |
N/A N/A |
Protagonist Therapeutics Inc | PTGX | PATEL DINESH V PH D President and CEO |
6,000 | $4.21 | 663,347 (Direct) |
View |
| 2023-05-31 Tax Withholding |
2023-06-02 7:51 pm |
N/A N/A |
Protagonist Therapeutics Inc | PTGX | Gupta Suneel Chief Development Officer |
4,150 | $26.07 | 148,037 (Direct) |
View |
| 2023-05-31 Option Award |
2023-06-02 7:51 pm |
N/A N/A |
Protagonist Therapeutics Inc | PTGX | Gupta Suneel Chief Development Officer |
12,000 | $0 | 148,037 (Direct) |
View |
| 2023-02-22 Gift |
2023-06-02 7:50 pm |
N/A N/A |
Protagonist Therapeutics Inc | PTGX | PATEL DINESH V PH D President and CEO |
10,000 | $0 | 602,946 (Direct) |
View |
| 2023-05-31 Tax Withholding |
2023-06-02 7:50 pm |
N/A N/A |
Protagonist Therapeutics Inc | PTGX | PATEL DINESH V PH D President and CEO |
12,165 | $26.07 | 602,946 (Direct) |
View |
| 2023-05-31 Option Award |
2023-06-02 7:50 pm |
N/A N/A |
Protagonist Therapeutics Inc | PTGX | PATEL DINESH V PH D President and CEO |
30,000 | $0 | 602,946 (Direct) |
View |
| 2023-05-31 Tax Withholding |
2023-06-02 7:48 pm |
N/A N/A |
Protagonist Therapeutics Inc | PTGX | Ali Asif Chief Financial Officer |
4,150 | $26.07 | 31,036 (Direct) |
View |
| 2023-05-31 Option Award |
2023-06-02 7:48 pm |
N/A N/A |
Protagonist Therapeutics Inc | PTGX | Ali Asif Chief Financial Officer |
12,000 | $0 | 31,036 (Direct) |
View |
| 2023-04-18 Tax Withholding |
2023-04-19 4:28 pm |
N/A N/A |
Protagonist Therapeutics Inc | PTGX | Ali Asif Chief Financial Officer |
1,189 | $23.21 | 23,186 (Direct) |
View |
| 2023-04-10 Exercise |
2023-04-11 7:18 pm |
N/A N/A |
Protagonist Therapeutics Inc | PTGX | SELICK HAROLD E Director |
6,196 | $0.87 | 21,506 (Direct) |
View |
| 2023-04-10 Exercise |
2023-04-11 7:18 pm |
N/A 2023-09-26 |
Protagonist Therapeutics Inc | PTGX | SELICK HAROLD E Director |
6,196 | $0 | 21,506 (Direct) |
View |
| 2023-01-16 Option Award |
2023-01-18 8:13 pm |
N/A 2033-01-15 |
Protagonist Therapeutics Inc | PTGX | Giraudo Bryan Director |
30,000 | $0 | 30,000 (Direct) |
View |
| 2023-01-16 Option Award |
2023-01-18 8:10 pm |
N/A 2033-01-15 |
Protagonist Therapeutics Inc | PTGX | Williams Lewis T Director |
30,000 | $0 | 30,000 (Direct) |
View |
| 2023-01-16 Option Award |
2023-01-18 8:07 pm |
N/A 2033-01-15 |
Protagonist Therapeutics Inc | PTGX | Waddill William D. Director |
30,000 | $0 | 30,000 (Direct) |
View |
| 2023-01-16 Option Award |
2023-01-18 8:03 pm |
N/A 2033-01-15 |
Protagonist Therapeutics Inc | PTGX | Noonberg Sarah B. Director |
30,000 | $0 | 30,000 (Direct) |
View |
| 2023-01-16 Option Award |
2023-01-18 8:00 pm |
N/A 2033-01-15 |
Protagonist Therapeutics Inc | PTGX | O'Dowd Sarah A Director |
30,000 | $0 | 30,000 (Direct) |
View |
| 2023-01-16 Option Award |
2023-01-18 7:58 pm |
N/A 2033-01-15 |
Protagonist Therapeutics Inc | PTGX | SELICK HAROLD E Director |
30,000 | $0 | 30,000 (Direct) |
View |
| 2023-01-16 Option Award |
2023-01-18 7:56 pm |
N/A 2033-01-15 |
Protagonist Therapeutics Inc | PTGX | Gupta Suneel Chief Development Officer |
144,375 | $0 | 261,937 (Direct) |
View |
| 2023-01-16 Option Award |
2023-01-18 7:53 pm |
N/A 2033-01-15 |
Protagonist Therapeutics Inc | PTGX | Ali Asif Chief Financial Officer |
74,375 | $0 | 88,125 (Direct) |
View |
| 2023-01-16 Option Award |
2023-01-18 7:51 pm |
N/A 2033-01-15 |
Protagonist Therapeutics Inc | PTGX | MOLINA ARTURO MD Chief Medical Officer |
21,875 | $0 | 43,125 (Direct) |
View |
| 2022-05-04 Gift |
2023-01-18 7:48 pm |
N/A N/A |
Protagonist Therapeutics Inc | PTGX | PATEL DINESH V PH D President and CEO |
6,116 | $0 | 1,198,096 (Direct) |
View |
| 2023-01-16 Option Award |
2023-01-18 7:48 pm |
N/A 2033-01-15 |
Protagonist Therapeutics Inc | PTGX | PATEL DINESH V PH D President and CEO |
600,000 | $0 | 1,198,096 (Direct) |
View |
| 2022-11-16 Exercise |
2022-11-17 6:24 pm |
N/A N/A |
Protagonist Therapeutics Inc | PTGX | Liu David Y Chief R&D Strategy Officer |
13,767 | $0.87 | 167,590 (Direct) |
View |
| 2022-11-16 Exercise |
2022-11-17 6:24 pm |
N/A N/A |
Protagonist Therapeutics Inc | PTGX | Liu David Y Chief R&D Strategy Officer |
35,656 | $1.16 | 167,590 (Direct) |
View |
| 2022-11-16 Exercise |
2022-11-17 6:24 pm |
N/A N/A |
Protagonist Therapeutics Inc | PTGX | Liu David Y Chief R&D Strategy Officer |
15,725 | $1.89 | 167,590 (Direct) |
View |
| 2022-11-16 Exercise |
2022-11-17 6:24 pm |
N/A 2023-09-26 |
Protagonist Therapeutics Inc | PTGX | Liu David Y Chief R&D Strategy Officer |
100,479 | $0 | 167,590 (Direct) |
View |
| 2022-11-16 Exercise |
2022-11-17 6:24 pm |
N/A N/A |
Protagonist Therapeutics Inc | PTGX | Liu David Y Chief R&D Strategy Officer |
35,331 | $4.21 | 167,590 (Direct) |
View |
| 2022-11-15 Option Award |
2022-11-17 6:22 pm |
N/A 2032-11-15 |
Protagonist Therapeutics Inc | PTGX | MOLINA ARTURO MD Chief Medical Officer |
148,750 | $0 | 148,750 (Direct) |
View |
| 2022-08-23 Exercise |
2022-08-24 6:15 pm |
N/A 2026-04-29 |
Protagonist Therapeutics Inc | PTGX | PATEL DINESH V PH D President and CEO |
20,000 | $0 | 664,048 (Direct) |
View |
| 2022-08-23 Exercise |
2022-08-24 6:15 pm |
N/A N/A |
Protagonist Therapeutics Inc | PTGX | PATEL DINESH V PH D President and CEO |
20,000 | $4.21 | 664,048 (Direct) |
View |
| 2022-05-26 Option Award |
2022-05-27 4:02 pm |
N/A 2032-05-26 |
Protagonist Therapeutics Inc | PTGX | Waddill William D. Director |
20,000 | $0 | 20,000 (Direct) |
View |
| 2022-05-26 Option Award |
2022-05-27 4:02 pm |
N/A 2032-05-26 |
Protagonist Therapeutics Inc | PTGX | O'Dowd Sarah A Director |
20,000 | $0 | 20,000 (Direct) |
View |
| 2022-05-26 Option Award |
2022-05-27 4:01 pm |
N/A 2032-05-26 |
Protagonist Therapeutics Inc | PTGX | Noonberg Sarah B. Director |
20,000 | $0 | 20,000 (Direct) |
View |
| 2022-05-26 Option Award |
2022-05-27 4:01 pm |
N/A 2032-05-26 |
Protagonist Therapeutics Inc | PTGX | Williams Lewis T Director |
20,000 | $0 | 20,000 (Direct) |
View |
| 2022-05-26 Option Award |
2022-05-27 4:00 pm |
N/A 2032-05-26 |
Protagonist Therapeutics Inc | PTGX | SELICK HAROLD E Director |
20,000 | $0 | 20,000 (Direct) |
View |
| 2022-05-26 Option Award |
2022-05-27 4:00 pm |
N/A 2032-05-26 |
Protagonist Therapeutics Inc | PTGX | Giraudo Bryan Director |
20,000 | $0 | 20,000 (Direct) |
View |
| 2022-05-03 Exercise |
2022-05-04 8:41 pm |
N/A N/A |
Protagonist Therapeutics Inc | PTGX | Waddill William D. Director |
12,000 | $8.59 | 12,000 (Direct) |
View |
| 2022-05-03 Exercise |
2022-05-04 8:41 pm |
N/A 2027-05-25 |
Protagonist Therapeutics Inc | PTGX | Waddill William D. Director |
12,000 | $0 | 12,000 (Direct) |
View |
| 2022-05-04 Exercise |
2022-05-04 8:33 pm |
N/A 2026-04-29 |
Protagonist Therapeutics Inc | PTGX | PATEL DINESH V PH D President and CEO |
15,742 | $0 | 664,048 (Direct) |
View |
| 2022-05-04 Exercise |
2022-05-04 8:33 pm |
N/A N/A |
Protagonist Therapeutics Inc | PTGX | PATEL DINESH V PH D President and CEO |
15,742 | $4.21 | 664,048 (Direct) |
View |